Holen Sie sich die Stockscreener-App
0.5047
1.16%
-0.0059
Handel nachbörslich:
.50
-0.0047
-0.93%
Schlusskurs vom Vortag:
$0.5106
Offen:
$0.5083
24-Stunden-Volumen:
332.75K
Relative Volume:
0.17
Marktkapitalisierung:
$30.03M
Einnahmen:
$2.06M
Nettoeinkommen (Verlust:
$-19.80M
KGV:
-0.7007
EPS:
-0.7203
Netto-Cashflow:
$-20.12M
1W Leistung:
-6.54%
1M Leistung:
-15.08%
6M Leistung:
-34.91%
1J Leistung:
-59.62%
1-Tages-Spanne:
$0.50
$0.5222
1-Wochen-Bereich:
$0.48
$0.5384
52-Wochen-Spanne:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Firmenname
Femasys Inc
Sektor
Telefon
770-500-3910
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.5047 | 30.38M | 2.06M | -19.80M | -20.12M | -0.7203 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
Femasys Inc Stock (FEMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-20 | Eingeleitet | Laidlaw | Buy |
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Forecast Cut: What dividend growth rate does Femasys Inc offerMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Femasys expands European presence with Swiss distribution deal By Investing.com - Investing.com Nigeria
Femasys Inc. Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - marketscreener.com
Femasys stock rises on new distribution partnership in Switzerland By Investing.com - Investing.com Australia
Femasys stock rises on new distribution partnership in Switzerland - Investing.com
Femasys expands European presence with Swiss distribution deal - Investing.com
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products - The Manila Times
Femasys Inc. Expands European Presence with New Distribution Partnership in Switzerland - Quiver Quantitative
Insider Sell: Is Omega Healthcare Investors Inc subject to activist investor interest2025 Major Catalysts & Smart Investment Allocation Tips - baoquankhu1.vn
Trading Action: Can Femasys Inc sustain its profitabilityTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn
Femasys Secures Major Order for FemBloc Launch - MSN
Travel Stocks: What is PCARs revenue forecastEarnings Trend Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Returns Recap: Does Ares Management Corporation meet Warren Buffetts criteria2025 Earnings Impact & Growth Oriented Trading Recommendations - baoquankhu1.vn
Femasys Receives Nasdaq Extension to Regain Listing Compliance - The Globe and Mail
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule - Investing.com
Femasys Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Stock Recap: Will FUFU benefit from geopolitical trendsCPI Data & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - Sahm
Femasys receives 180-day Nasdaq extension to meet minimum bid price - Investing.com Nigeria
Femasys secures Nasdaq extension to regain bid price compliance - MSN
Femasys Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Requirement - TradingView
Nasdaq gives Femasys more time to fix sub-$1 share price by July 2026 - Stock Titan
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment - Investing.com Nigeria
Dow Update: Why Femasys Inc stock attracts global investorsTrade Volume Summary & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment By Investing.com - Investing.com South Africa
Femasys Inc. Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed®? in Community-Based Care - marketscreener.com
Femasys Inc. Partners with Refuah Health Center to Enhance Accessibility of FemaSeed for Infertility Treatment - Quiver Quantitative
Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care - The Manila Times
Will Femasys Inc. stock maintain growth storyGap Up & Reliable Breakout Stock Forecasts - ulpravda.ru
What valuation multiples suggest for Femasys Inc. stockJuly 2025 Update & Safe Capital Growth Stock Tips - Улправда
Published on: 2026-01-09 05:32:45 - Улправда
Can Femasys Inc. stock rebound after recent weaknessPortfolio Return Report & Expert Approved Trade Ideas - Улправда
How Femasys Inc. stock performs after earnings2025 Price Momentum & Weekly High Momentum Picks - Улправда
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com Nigeria
How Femasys Inc. stock reacts to inflationary pressures2026 world cup usa national team group stage goalkeepers counter attacking expert forecast guide - ulpravda.ru
Earnings Beat: Will MARZ stock keep high P E multiples2025 Biggest Moves & Pattern Based Trade Signal System - moha.gov.vn
Femasys gains UK approval for women's health products - MSN
Market Leaders: How strong is Femasys Inc stock balance sheetQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - Bộ Nội Vụ
User | theeveningleader.comFemasys Inc.Common Stock (Nasdaq:FEMY) Stock Quote - FinancialContent
Femasys files for at-the-market offering of up to $9.8 million in common stock - Investing.com India
Femasys Launches At-the-Market Common Stock Offering - TipRanks
Femasys files for at-the-market offering of up to $9.8 million in common stock By Investing.com - Investing.com South Africa
Femasys Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Suwanee company Femasys Inc. gets FDA approval for diagnostic device - The Business Journals
Finanzdaten der Femasys Inc-Aktie (FEMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):